fepblue glp 1 2025 GLP-1 Pipeline Update: May - Prime Therapeutics GLP-1 RA prescription trends: January

Arachidonic acid (AA) is the precursor for prostaglandin E 2 (PGE 2 ) synthesis and increases growth of prostate cancer cells (Van et al., 1998)

While Bioma offers a versatile solution that may fit a wide range of health goals, it is particularly well-suited for certain groups facing specific challenges tied to microbiome imbalances

All other evidence is from rodent and in vitro models

As described in the CY 2026 PFS proposed rule (90 FR 32648 through 32650), our policies on the amount of time an ACO can participate under a one-sided model of the Shared Savings Program, and progression to two-sided risk, have varied over time, including as a result of changes finalized with the CY 2023 PFS final rule (see 87 FR 69805 through 69818)

By influencing cellular movement, TB-500 enables researchers to explore systemic tissue remodeling and soft tissue repair